-
1
-
-
84924271853
-
Global cancer statistics, 2012
-
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
-
(2015)
CA Cancer J Clin
, vol.65
, pp. 87-108
-
-
Torre, L.A.1
Bray, F.2
Siegel, R.L.3
Ferlay, J.4
Lortet-Tieulent, J.5
Jemal, A.6
-
2
-
-
84892805731
-
Cancer statistics, 2014
-
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
-
(2014)
CA Cancer J Clin
, vol.64
, pp. 9-29
-
-
Siegel, R.1
Ma, J.2
Zou, Z.3
Jemal, A.4
-
3
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
-
(2005)
Lancet
, vol.365
, pp. 1687-1717
-
-
-
4
-
-
33750313208
-
Cancer stem cells: Perspectives on current status and future directions: AACR Workshop on cancer stem cells
-
Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells: perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-44.
-
(2006)
Cancer Res
, vol.66
, pp. 9339-9344
-
-
Clarke, M.F.1
Dick, J.E.2
Dirks, P.B.3
Eaves, C.J.4
Jamieson, C.H.5
Jones, D.L.6
-
5
-
-
84892554828
-
Oncogenic somatic events in tissue-specific stem cells: A role in cancer recurrence?
-
Hartwig FP, Nedel F, Collares T, Tarquinio SB, Nör JE, Demarco FF. Oncogenic somatic events in tissue-specific stem cells: a role in cancer recurrence? Ageing Res Rev 2014;13:100-6.
-
(2014)
Ageing Res Rev
, vol.13
, pp. 100-106
-
-
Hartwig, F.P.1
Nedel, F.2
Collares, T.3
Tarquinio, S.B.4
Nör, J.E.5
Demarco, F.F.6
-
6
-
-
84880828444
-
Invasive cancers are not necessarily from preformed in situ tumours: An alternative way of carcinogenesis from misplaced stem cells
-
Wang RA, Li ZS, Zhang HZ, Zheng PJ, Li QL, Shi JG, et al. Invasive cancers are not necessarily from preformed in situ tumours: an alternative way of carcinogenesis from misplaced stem cells. J Cell Mol Med 2013;17:921-6.
-
(2013)
J Cell Mol Med
, vol.17
, pp. 921-926
-
-
Wang, R.A.1
Li, Z.S.2
Zhang, H.Z.3
Zheng, P.J.4
Li, Q.L.5
Shi, J.G.6
-
8
-
-
84897823423
-
Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization
-
Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, et al. Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol 2014;184:985-95.
-
(2014)
Am J Pathol
, vol.184
, pp. 985-995
-
-
Gorden, B.H.1
Kim, J.H.2
Sarver, A.L.3
Frantz, A.M.4
Breen, M.5
Lindblad-Toh, K.6
-
9
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-8.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 3983-3988
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
10
-
-
21344454219
-
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
-
Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506-11.
-
(2005)
Cancer Res
, vol.65
, pp. 5506-5511
-
-
Ponti, D.1
Costa, A.2
Zaffaroni, N.3
Pratesi, G.4
Petrangolini, G.5
Coradini, D.6
-
11
-
-
42549142322
-
BRCA1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics
-
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. BRCA1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008;10:R10.
-
(2008)
Breast Cancer Res
, vol.10
, pp. 10
-
-
Wright, M.H.1
Calcagno, A.M.2
Salcido, C.D.3
Carlson, M.D.4
Ambudkar, S.V.5
Varticovski, L.6
-
12
-
-
84866431362
-
In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas
-
Perrone G, Gaeta LM, Zagami M, Nasorri F, Coppola R, Borzomati D, et al. In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas. PLoS One 2012;7:e43110.
-
(2012)
Plos One
, vol.7
-
-
Perrone, G.1
Gaeta, L.M.2
Zagami, M.3
Nasorri, F.4
Coppola, R.5
Borzomati, D.6
-
13
-
-
84879443767
-
Isolation and characterization of human breast tumor stem cells
-
Wang LB, He YQ, Wu LG, Chen DM, Fan H, Jia W. Isolation and characterization of human breast tumor stem cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2012;28:1261-4.
-
(2012)
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
, vol.28
, pp. 1261-1264
-
-
Wang, L.B.1
He, Y.Q.2
Wu, L.G.3
Chen, D.M.4
Fan, H.5
Jia, W.6
-
14
-
-
0032791736
-
Adhesion proteins in the biology of breast cancer: Contribution of CD44
-
Herrera-Gayol A, Jothy S. Adhesion proteins in the biology of breast cancer: contribution of CD44. Exp Mol Pathol 1999;66:149-56.
-
(1999)
Exp Mol Pathol
, vol.66
, pp. 149-156
-
-
Herrera-Gayol, A.1
Jothy, S.2
-
15
-
-
32644467590
-
Osteopontin: Role in cell signaling and cancer progression
-
Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006;16:79-87.
-
(2006)
Trends Cell Biol
, vol.16
, pp. 79-87
-
-
Rangaswami, H.1
Bulbule, A.2
Kundu, G.C.3
-
16
-
-
33751270222
-
Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective
-
Götte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006;66:10233-7.
-
(2006)
Cancer Res
, vol.66
, pp. 10233-10237
-
-
Götte, M.1
Yip, G.W.2
-
17
-
-
32244439441
-
CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells
-
Schabath H, Runz S, Joumaa S, Altevogt P. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 2006;119(Pt 2):314-25.
-
(2006)
J Cell Sci
, vol.119
, pp. 314-325
-
-
Schabath, H.1
Runz, S.2
Joumaa, S.3
Altevogt, P.4
-
18
-
-
84903768676
-
Tackling the cancer stem cells: What challenges do they pose?
-
Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells: what challenges do they pose? Nat Rev Drug Discov 2014;13:497-512.
-
(2014)
Nat Rev Drug Discov
, vol.13
, pp. 497-512
-
-
Pattabiraman, D.R.1
Weinberg, R.A.2
-
19
-
-
35848955428
-
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
-
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-67.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
Monville, F.4
Dutcher, J.5
Brown, M.6
-
20
-
-
36048931144
-
Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1
-
Balicki D. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1. Cell Stem Cell 2007;1: 485-7.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 485-487
-
-
Balicki, D.1
-
21
-
-
33746846201
-
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
-
Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A 2006;103:11707-12.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 11707-11712
-
-
Chute, J.P.1
Muramoto, G.G.2
Whitesides, J.3
Colvin, M.4
Safi, R.5
Chao, N.J.6
-
22
-
-
77953163539
-
CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer
-
Meyer MJ, Fleming JM, Lin AF, Hussnain SA, Ginsburg E, Vonderhaar BK. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. Cancer Res 2010;70:4624-33.
-
(2010)
Cancer Res
, vol.70
, pp. 4624-4633
-
-
Meyer, M.J.1
Fleming, J.M.2
Lin, A.F.3
Hussnain, S.A.4
Ginsburg, E.5
Vonderhaar, B.K.6
-
23
-
-
36849013105
-
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line
-
Cariati M, Naderi A, Brown JP, Smalley MJ, Pinder SE, Caldas C, et al. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 2008;122:298-304.
-
(2008)
Int J Cancer
, vol.122
, pp. 298-304
-
-
Cariati, M.1
Naderi, A.2
Brown, J.P.3
Smalley, M.J.4
Pinder, S.E.5
Caldas, C.6
-
24
-
-
54249086214
-
The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis
-
Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008;68:7711-7.
-
(2008)
Cancer Res
, vol.68
, pp. 7711-7717
-
-
Vaillant, F.1
Asselin-Labat, M.L.2
Shackleton, M.3
Forrest, N.C.4
Lindeman, G.J.5
Visvader, J.E.6
-
25
-
-
84887019122
-
Discovery of the cancer stem cell related determinants of radioresistance
-
Peitzsch C, Kurth I, Kunz-Schughart L, Baumann M, Dubrovska A. Discovery of the cancer stem cell related determinants of radioresistance. Radiother Oncol 2013;108:378-87.
-
(2013)
Radiother Oncol
, vol.108
, pp. 378-387
-
-
Peitzsch, C.1
Kurth, I.2
Kunz-Schughart, L.3
Baumann, M.4
Dubrovska, A.5
-
26
-
-
84872491549
-
Developmental signaling pathways in cancer stem cells of solid tumors
-
Karamboulas C, Ailles L. Developmental signaling pathways in cancer stem cells of solid tumors. Biochim Biophys Acta 2013;1830:2481-95.
-
(2013)
Biochim Biophys Acta
, vol.1830
, pp. 2481-2495
-
-
Karamboulas, C.1
Ailles, L.2
-
27
-
-
84869880156
-
Epigenetic alterations involved in cancer stem cell reprogramming
-
Muñoz P, Iliou MS, Esteller M. Epigenetic alterations involved in cancer stem cell reprogramming. Mol Oncol 2012;6:620-36.
-
(2012)
Mol Oncol
, vol.6
, pp. 620-636
-
-
Muñoz, P.1
Iliou, M.S.2
Esteller, M.3
-
28
-
-
59649100796
-
Wnt signaling controls the fate of mesenchymal stem cells
-
Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009;433:1-7.
-
(2009)
Gene
, vol.433
, pp. 1-7
-
-
Ling, L.1
Nurcombe, V.2
Cool, S.M.3
-
29
-
-
33745728170
-
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells
-
Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66:6063-71.
-
(2006)
Cancer Res
, vol.66
, pp. 6063-6071
-
-
Liu, S.1
Dontu, G.2
Mantle, I.D.3
Patel, S.4
Ahn, N.S.5
Jackson, K.W.6
-
30
-
-
50849111710
-
Rational targeting of Notch signaling in cancer
-
Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene 2008;27:5124-31.
-
(2008)
Oncogene
, vol.27
, pp. 5124-5131
-
-
Rizzo, P.1
Osipo, C.2
Foreman, K.3
Golde, T.4
Osborne, B.5
Miele, L.6
-
31
-
-
36248953716
-
Mammary stem cells and breast cancer: Role of Notch signalling
-
Farnie G, Clarke RB. Mammary stem cells and breast cancer: role of Notch signalling. Stem Cell Rev 2007;3:169-75.
-
(2007)
Stem Cell Rev
, vol.3
, pp. 169-175
-
-
Farnie, G.1
Clarke, R.B.2
-
32
-
-
37349040710
-
Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors
-
Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif 2008;41 Suppl 1:51-6.
-
(2008)
Cell Prolif
, vol.41
, pp. 51-56
-
-
Yamanaka, S.1
-
33
-
-
33947587857
-
Sox2: A possible driver of the basal-like phenotype in sporadic breast cancer
-
Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G, Rodriguez-Gil Y, Martinez MA, Hernandez L, et al. Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol 2007;20:474-81.
-
(2007)
Mod Pathol
, vol.20
, pp. 474-481
-
-
Rodriguez-Pinilla, S.M.1
Sarrio, D.2
Moreno-Bueno, G.3
Rodriguez-Gil, Y.4
Martinez, M.A.5
Hernandez, L.6
-
34
-
-
84858341630
-
Sox2 expression in breast tumours and activation in breast cancer stem cells
-
Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 2012;31:1354-65.
-
(2012)
Oncogene
, vol.31
, pp. 1354-1365
-
-
Leis, O.1
Eguiara, A.2
Lopez-Arribillaga, E.3
Alberdi, M.J.4
Hernandez-Garcia, S.5
Elorriaga, K.6
-
35
-
-
84865767219
-
SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression
-
Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 2012;72:4597-608.
-
(2012)
Cancer Res
, vol.72
, pp. 4597-4608
-
-
Zhang, J.1
Liang, Q.2
Lei, Y.3
Yao, M.4
Li, L.5
Gao, X.6
-
36
-
-
36248966518
-
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
-
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72.
-
(2007)
Cell
, vol.131
, pp. 861-872
-
-
Takahashi, K.1
Tanabe, K.2
Ohnuki, M.3
Narita, M.4
Ichisaka, T.5
Tomoda, K.6
-
37
-
-
42649112047
-
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
-
Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507.
-
(2008)
Nat Genet
, vol.40
, pp. 499-507
-
-
Ben-Porath, I.1
Thomson, M.W.2
Carey, V.J.3
Ge, R.4
Bell, G.W.5
Regev, A.6
-
38
-
-
84864922025
-
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
-
Stolzenburg S, Rots MG, Beltran AS, Rivenbark AG, Yuan X, Qian H, et al. Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Res 2012;40:6725-40.
-
(2012)
Nucleic Acids Res
, vol.40
, pp. 6725-6740
-
-
Stolzenburg, S.1
Rots, M.G.2
Beltran, A.S.3
Rivenbark, A.G.4
Yuan, X.5
Qian, H.6
-
39
-
-
84901190709
-
The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis
-
Lu X, Mazur SJ, Lin T, Appella E, Xu Y. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene 2014;33:2655-64.
-
(2014)
Oncogene
, vol.33
, pp. 2655-2664
-
-
Lu, X.1
Mazur, S.J.2
Lin, T.3
Appella, E.4
Xu, Y.5
-
40
-
-
84873741701
-
Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma
-
Luo W, Li S, Peng B, Ye Y, Deng X, Yao K. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One 2013;8:e56324.
-
(2013)
Plos One
, vol.8
-
-
Luo, W.1
Li, S.2
Peng, B.3
Ye, Y.4
Deng, X.5
Yao, K.6
-
41
-
-
77956178360
-
EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer
-
Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010;29:4741-51.
-
(2010)
Oncogene
, vol.29
, pp. 4741-4751
-
-
Singh, A.1
Settleman, J.2
-
42
-
-
69549131213
-
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
-
Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 2009;106:13820-5.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 13820-13825
-
-
Creighton, C.J.1
Li, X.2
Landis, M.3
Dixon, J.M.4
Neumeister, V.M.5
Sjolund, A.6
-
43
-
-
77954861745
-
Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer
-
Creighton CJ, Chang JC, Rosen JM. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 2010;15:253-60.
-
(2010)
J Mammary Gland Biol Neoplasia
, vol.15
, pp. 253-260
-
-
Creighton, C.J.1
Chang, J.C.2
Rosen, J.M.3
-
44
-
-
65249155400
-
Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells
-
Li QQ, Xu JD, Wang WJ, Cao XX, Chen Q, Tang F, et al. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin Cancer Res 2009;15:2657-65.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2657-2665
-
-
Li, Q.Q.1
Xu, J.D.2
Wang, W.J.3
Cao, X.X.4
Chen, Q.5
Tang, F.6
-
45
-
-
58149334773
-
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
-
Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 2009;15:68-74.
-
(2009)
Nat Med
, vol.15
, pp. 68-74
-
-
Farmer, P.1
Bonnefoi, H.2
Erle, P.3
Cameron, D.4
Wirapati, P.5
Becette, V.6
-
46
-
-
33244463813
-
Complex networks orchestrate epithelial-mesenchymal transitions
-
Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 131-142
-
-
Thiery, J.P.1
Sleeman, J.P.2
-
47
-
-
34848826864
-
Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression
-
Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression. J Cell Physiol 2007;213:374-83.
-
(2007)
J Cell Physiol
, vol.213
, pp. 374-383
-
-
Hugo, H.1
Ackland, M.L.2
Blick, T.3
Lawrence, M.G.4
Clements, J.A.5
Williams, E.D.6
-
48
-
-
84875473628
-
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer
-
Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, et al. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res 2013;73:1981-92.
-
(2013)
Cancer Res
, vol.73
, pp. 1981-1992
-
-
Hollier, B.G.1
Tinnirello, A.A.2
Werden, S.J.3
Evans, K.W.4
Taube, J.H.5
Sarkar, T.R.6
-
49
-
-
33947192053
-
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
-
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007;67:1979-87.
-
(2007)
Cancer Res
, vol.67
, pp. 1979-1987
-
-
Cheng, G.Z.1
Chan, J.2
Wang, Q.3
Zhang, W.4
Sun, C.D.5
Wang, L.H.6
-
50
-
-
28844494352
-
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation
-
Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R, et al. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 2006;118:290-301.
-
(2006)
Int J Cancer
, vol.118
, pp. 290-301
-
-
Hiscox, S.1
Jiang, W.G.2
Obermeier, K.3
Taylor, K.4
Morgan, L.5
Burmi, R.6
-
51
-
-
79551555038
-
Cancer stem cell niche: The place to be
-
Borovski T, De Sousa E Melo F, Vermeulen L, Medema JP. Cancer stem cell niche: the place to be. Cancer Res 2011;71:634-9.
-
(2011)
Cancer Res
, vol.71
, pp. 634-639
-
-
Borovski, T.1
De Sousa, E.2
Melo, F.3
Vermeulen, L.4
Medema, J.P.5
-
52
-
-
80053531658
-
Regulation of cancer stem cells by cytokine networks: Attacking cancer’s inflammatory roots
-
Korkaya H, Liu S, Wicha MS. Regulation of cancer stem cells by cytokine networks: attacking cancer’s inflammatory roots. Clin Cancer Res 2011;17:6125-9.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 6125-6129
-
-
Korkaya, H.1
Liu, S.2
Wicha, M.S.3
-
53
-
-
84979993218
-
Tumor twitter: Cellular communication in the breast cancer stem cell niche
-
Brooks MD, Wicha MS. Tumor twitter: cellular communication in the breast cancer stem cell niche. Cancer Discov 2015;5:469-71.
-
(2015)
Cancer Discov
, vol.5
, pp. 469-471
-
-
Brooks, M.D.1
Wicha, M.S.2
-
54
-
-
84865401715
-
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population
-
Korkaya H, Kim GI, Davis A, Malik F, Henry NL, Ithimakin S, et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol Cell 2012;47:570-84.
-
(2012)
Mol Cell
, vol.47
, pp. 570-584
-
-
Korkaya, H.1
Kim, G.I.2
Davis, A.3
Malik, F.4
Henry, N.L.5
Ithimakin, S.6
-
55
-
-
84874607100
-
TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer
-
Bhola NE, Balko JM, Dugger TC, Kuba MG, Sánchez V, Sanders M, et al. TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer. J Clin Invest 2013;123:1348-58.
-
(2013)
J Clin Invest
, vol.123
, pp. 1348-1358
-
-
Bhola, N.E.1
Balko, J.M.2
Dugger, T.C.3
Kuba, M.G.4
Sánchez, V.5
Sanders, M.6
-
56
-
-
76649113726
-
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
-
Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 2010;120:485-97.
-
(2010)
J Clin Invest
, vol.120
, pp. 485-497
-
-
Ginestier, C.1
Liu, S.2
Diebel, M.E.3
Korkaya, H.4
Luo, M.5
Brown, M.6
-
57
-
-
66149150580
-
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
-
Azab AK, Runnels JM, Pitsillides C, Moreau AS, Azab F, Leleu X, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 2009;113:4341-51.
-
(2009)
Blood
, vol.113
, pp. 4341-4351
-
-
Azab, A.K.1
Runnels, J.M.2
Pitsillides, C.3
Moreau, A.S.4
Azab, F.5
Leleu, X.6
-
58
-
-
33846254013
-
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
-
Zeng Z, Samudio IJ, Munsell M, An J, Huang Z, Estey E, et al. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther 2006;5:3113-21.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 3113-3121
-
-
Zeng, Z.1
Samudio, I.J.2
Munsell, M.3
An, J.4
Huang, Z.5
Estey, E.6
-
59
-
-
84863180510
-
CXCR4 expression in prostate cancer progenitor cells
-
Dubrovska A, Elliott J, Salamone RJ, Telegeev GD, Stakhovsky AE, Schepotin IB, et al. CXCR4 expression in prostate cancer progenitor cells. PLoS One 2012;7:e31226.
-
(2012)
Plos One
, vol.7
-
-
Dubrovska, A.1
Elliott, J.2
Salamone, R.J.3
Telegeev, G.D.4
Stakhovsky, A.E.5
Schepotin, I.B.6
-
60
-
-
84866895030
-
Molecular pathways: Emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment
-
Kuonen F, Secondini C, Rüegg C. Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment. Clin Cancer Res 2012; 18:5196-202.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 5196-5202
-
-
Kuonen, F.1
Secondini, C.2
Rüegg, C.3
-
61
-
-
33646720082
-
Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: Implications for radiotherapy of hepatocellular carcinoma
-
Chung YL, Jian JJ, Cheng SH, Tsai SY, Chuang VP, Soong T, et al. Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clin Cancer Res 2006;12:2706-15.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2706-2715
-
-
Chung, Y.L.1
Jian, J.J.2
Cheng, S.H.3
Tsai, S.Y.4
Chuang, V.P.5
Soong, T.6
-
62
-
-
77955286548
-
Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis
-
Sofia Vala I, Martins LR, Imaizumi N, Nunes RJ, Rino J, Kuonen F, et al. Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One 2010;5:e11222.
-
(2010)
Plos One
, vol.5
-
-
Sofia Vala, I.1
Martins, L.R.2
Imaizumi, N.3
Nunes, R.J.4
Rino, J.5
Kuonen, F.6
-
63
-
-
34347240794
-
Chemical radiosensitizers for use in radiotherapy
-
Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol) 2007;19:397-417.
-
(2007)
Clin Oncol (R Coll Radiol)
, vol.19
, pp. 397-417
-
-
Wardman, P.1
-
64
-
-
84887419886
-
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
-
Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, et al. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A 2013;110:19059-64.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 19059-19064
-
-
Batchelor, T.T.1
Gerstner, E.R.2
Emblem, K.E.3
Duda, D.G.4
Kalpathy-Cramer, J.5
Snuderl, M.6
-
65
-
-
73149110562
-
Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content
-
Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010;140:62-73.
-
(2010)
Cell
, vol.140
, pp. 62-73
-
-
Pece, S.1
Tosoni, D.2
Confalonieri, S.3
Mazzarol, G.4
Vecchi, M.5
Ronzoni, S.6
-
66
-
-
84894231936
-
A ROS/STAT3/HIF-1alpha signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion
-
Cho KH, Choi MJ, Jeong KJ, Kim JJ, Hwang MH, Shin SC, et al. A ROS/STAT3/HIF-1alpha signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion. Prostate 2014;74:528-36.
-
(2014)
Prostate
, vol.74
, pp. 528-536
-
-
Cho, K.H.1
Choi, M.J.2
Jeong, K.J.3
Kim, J.J.4
Hwang, M.H.5
Shin, S.C.6
-
67
-
-
84885237107
-
Emerging targets in cancer management: Role of the CXCL12/CXCR4 axis
-
Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. Onco Targets Ther 2013;6:1347-61.
-
(2013)
Onco Targets Ther
, vol.6
, pp. 1347-1361
-
-
Cojoc, M.1
Peitzsch, C.2
Trautmann, F.3
Polishchuk, L.4
Telegeev, G.D.5
Dubrovska, A.6
-
68
-
-
84855708762
-
HIF-1alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
-
Qiang L, Wu T, Zhang HW, Lu N, Hu R, Wang YJ, et al. HIF-1alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ 2012;19:284-94.
-
(2012)
Cell Death Differ
, vol.19
, pp. 284-294
-
-
Qiang, L.1
Wu, T.2
Zhang, H.W.3
Lu, N.4
Hu, R.5
Wang, Y.J.6
-
69
-
-
78650401560
-
HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin
-
Choi H, Chun YS, Kim TY, Park JW. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin. Cancer Res 2010;70:10101-11.
-
(2010)
Cancer Res
, vol.70
, pp. 10101-10111
-
-
Choi, H.1
Chun, Y.S.2
Kim, T.Y.3
Park, J.W.4
-
70
-
-
84859445000
-
Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy
-
Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012;33: 207-14.
-
(2012)
Trends Pharmacol Sci
, vol.33
, pp. 207-214
-
-
Semenza, G.L.1
-
71
-
-
33748037026
-
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer
-
Generali D, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield S, et al. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 2006;12:4562-8.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 4562-4568
-
-
Generali, D.1
Berruti, A.2
Brizzi, M.P.3
Campo, L.4
Bonardi, S.5
Wigfield, S.6
-
73
-
-
0036364467
-
Multidrug resistance in cancer: Role of ATP-dependent transporters
-
Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 48-58
-
-
Gottesman, M.M.1
Fojo, T.2
Bates, S.E.3
-
74
-
-
65549121495
-
Human ATP-binding cassette (ABC) transporter family
-
Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Hum Genomics 2009;3:281-90.
-
(2009)
Hum Genomics
, vol.3
, pp. 281-290
-
-
Vasiliou, V.1
Vasiliou, K.2
Nebert, D.W.3
-
75
-
-
0141888537
-
The role of ABC transporters in clinical practice
-
Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinical practice. Oncologist 2003;8:411-24.
-
(2003)
Oncologist
, vol.8
, pp. 411-424
-
-
Leonard, G.D.1
Fojo, T.2
Bates, S.E.3
-
76
-
-
84894230005
-
BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib
-
Huang WC, Hsieh YL, Hung CM, Chien PH, Chien YF, Chen LC, et al. BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib. PLoS One 2013;8:e83627.
-
(2013)
Plos One
, vol.8
-
-
Huang, W.C.1
Hsieh, Y.L.2
Hung, C.M.3
Chien, P.H.4
Chien, Y.F.5
Chen, L.C.6
-
77
-
-
84878737464
-
ABCG2: Recent discovery of potent and highly selective inhibitors
-
Lecerf-Schmidt F, Peres B, Valdameri G, Gauthier C, Winter E, Payen L, et al. ABCG2: recent discovery of potent and highly selective inhibitors. Future Med Chem 2013;5:1037-45.
-
(2013)
Future Med Chem
, vol.5
, pp. 1037-1045
-
-
Lecerf-Schmidt, F.1
Peres, B.2
Valdameri, G.3
Gauthier, C.4
Winter, E.5
Payen, L.6
-
78
-
-
84885972386
-
Molecular pharmacology of ABCG2 and its role in chemoresistance
-
Stacy AE, Jansson PJ, Richardson DR. Molecular pharmacology of ABCG2 and its role in chemoresistance. Mol Pharmacol 2013;84:655-69.
-
(2013)
Mol Pharmacol
, vol.84
, pp. 655-669
-
-
Stacy, A.E.1
Jansson, P.J.2
Richardson, D.R.3
-
79
-
-
79955025420
-
The role of human aldehyde dehydrogenase in normal and cancer stem cells
-
Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2011;7:292-306.
-
(2011)
Stem Cell Rev
, vol.7
, pp. 292-306
-
-
Ma, I.1
Allan, A.L.2
-
80
-
-
67649239963
-
GABA’s control of stem and cancer cell proliferation in adult neural and peripheral niches
-
Young SZ, Bordey A. GABA’s control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology (Bethesda) 2009;24:171-85.
-
(2009)
Physiology (Bethesda)
, vol.24
, pp. 171-185
-
-
Young, S.Z.1
Bordey, A.2
-
81
-
-
84872117242
-
Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress
-
Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, et al. Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med 2013;56:89-101.
-
(2013)
Free Radic Biol Med
, vol.56
, pp. 89-101
-
-
Singh, S.1
Brocker, C.2
Koppaka, V.3
Chen, Y.4
Jackson, B.C.5
Matsumoto, A.6
-
82
-
-
72949118673
-
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
-
Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 2009;13:2236-52.
-
(2009)
J Cell Mol Med
, vol.13
, pp. 2236-2252
-
-
Croker, A.K.1
Goodale, D.2
Chu, J.3
Postenka, C.4
Hedley, B.D.5
Hess, D.A.6
-
83
-
-
0030024868
-
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer
-
Magni M, Shammah S, Schiró R, Mellado W, Dalla-Favera R, Gianni AM. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 1996;87:1097-103.
-
(1996)
Blood
, vol.87
, pp. 1097-1103
-
-
Magni, M.1
Shammah, S.2
Schiró, R.3
Mellado, W.4
Dalla-Favera, R.5
Gianni, A.M.6
-
84
-
-
84893130358
-
Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells
-
Parajuli B, Fishel ML, Hurley TD. Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells. J Med Chem 2014;57:449-61.
-
(2014)
J Med Chem
, vol.57
, pp. 449-461
-
-
Parajuli, B.1
Fishel, M.L.2
Hurley, T.D.3
-
85
-
-
67449113764
-
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers
-
Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 2009;15: 4234-41.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 4234-4241
-
-
Tanei, T.1
Morimoto, K.2
Shimazu, K.3
Kim, S.J.4
Tanji, Y.5
Taguchi, T.6
-
86
-
-
84878235773
-
DNA-damaging agents in cancer chemotherapy: Serendipity and chemical biology
-
Cheung-Ong K, Giaever G, Nislow C. DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem Biol 2013;20:648-59.
-
(2013)
Chem Biol
, vol.20
, pp. 648-659
-
-
Cheung-Ong, K.1
Giaever, G.2
Nislow, C.3
-
87
-
-
79958784379
-
Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fraction
-
Al-Assar O, Mantoni T, Lunardi S, Kingham G, Helleday T, Brunner TB. Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fraction. Cancer Biol Ther 2011;11:1028-35.
-
(2011)
Cancer Biol Ther
, vol.11
, pp. 1028-1035
-
-
Al-Assar, O.1
Mantoni, T.2
Lunardi, S.3
Kingham, G.4
Helleday, T.5
Brunner, T.B.6
-
88
-
-
84869779399
-
Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: Role of ATM
-
Kim SY, Rhee JG, Song X, Prochownik EV, Spitz DR, Lee YJ. Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM. PLoS One 2012;7:e50423.
-
(2012)
Plos One
, vol.7
-
-
Kim, S.Y.1
Rhee, J.G.2
Song, X.3
Prochownik, E.V.4
Spitz, D.R.5
Lee, Y.J.6
-
89
-
-
84873440196
-
Pathway choice in DNA double strand break repair: Observations of a balancing act
-
Brandsma I, Gent DC. Pathway choice in DNA double strand break repair: observations of a balancing act. Genome Integr 2012;3:9.
-
(2012)
Genome Integr
, vol.3
, pp. 9
-
-
Brandsma, I.1
Gent, D.C.2
-
91
-
-
0036261707
-
Sensing and repairing DNA double-strand breaks
-
Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002;23:687-96.
-
(2002)
Carcinogenesis
, vol.23
, pp. 687-696
-
-
Jackson, S.P.1
-
92
-
-
33344476097
-
DNA damage checkpoints in mammals
-
Niida H, Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis 2006;21:3-9.
-
(2006)
Mutagenesis
, vol.21
, pp. 3-9
-
-
Niida, H.1
Nakanishi, M.2
-
93
-
-
80052841288
-
The phenotypic radiation resistance of CD44+/CD24(- or low) breast cancer cells is mediated through the enhanced activation of ATM signaling
-
Yin H, Glass J. The phenotypic radiation resistance of CD44+/CD24(- or low) breast cancer cells is mediated through the enhanced activation of ATM signaling. PLoS One 2011;6:e24080.
-
(2011)
Plos One
, vol.6
-
-
Yin, H.1
Glass, J.2
-
94
-
-
84868007565
-
Physiological roles of mitochondrial reactive oxygen species
-
Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012;48:158-67.
-
(2012)
Mol Cell
, vol.48
, pp. 158-167
-
-
Sena, L.A.1
Chandel, N.S.2
-
95
-
-
3142519833
-
Oxidative stress, redox, and the tumor microenvironment
-
Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol 2004;14:259-66.
-
(2004)
Semin Radiat Oncol
, vol.14
, pp. 259-266
-
-
Cook, J.A.1
Gius, D.2
Wink, D.A.3
Krishna, M.C.4
Russo, A.5
Mitchell, J.B.6
-
96
-
-
67650071137
-
Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?
-
Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009;8:579-91.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 579-591
-
-
Trachootham, D.1
Alexandre, J.2
Huang, P.3
-
97
-
-
64749093574
-
Association of reactive oxygen species levels and radioresistance in cancer stem cells
-
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009;458:780-3.
-
(2009)
Nature
, vol.458
, pp. 780-783
-
-
Diehn, M.1
Cho, R.W.2
Lobo, N.A.3
Kalisky, T.4
Dorie, M.J.5
Kulp, A.N.6
-
98
-
-
84885352426
-
Origins of metastatic traits
-
Vanharanta S, Massagué J. Origins of metastatic traits. Cancer Cell 2013;24:410-21.
-
(2013)
Cancer Cell
, vol.24
, pp. 410-421
-
-
Vanharanta, S.1
Massagué, J.2
-
99
-
-
36049047008
-
Reducing the risk of distant metastases in breast cancer patients: Role of aromatase inhibitors
-
Del Mastro L, Clavarezza M, Venturini M. Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors. Cancer Treat Rev 2007;33:681-7.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 681-687
-
-
Del Mastro, L.1
Clavarezza, M.2
Venturini, M.3
-
100
-
-
0027096666
-
Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces
-
Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 1992;3:1169-80.
-
(1992)
Mol Biol Cell
, vol.3
, pp. 1169-1180
-
-
Brown, L.F.1
Berse, B.2
Van De Water, L.3
Papadopoulos-Sergiou, A.4
Perruzzi, C.A.5
Manseau, E.J.6
-
101
-
-
6344258588
-
The role of osteopontin in tumor metastasis
-
Wai PY, Kuo PC. The role of osteopontin in tumor metastasis. J Surg Res 2004;121:228-41.
-
(2004)
J Surg Res
, vol.121
, pp. 228-241
-
-
Wai, P.Y.1
Kuo, P.C.2
-
102
-
-
39149110606
-
Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms
-
Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res 2008;68:152-61.
-
(2008)
Cancer Res
, vol.68
, pp. 152-161
-
-
Chakraborty, G.1
Jain, S.2
Kundu, G.C.3
-
103
-
-
4143149778
-
CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells
-
Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004;64:5702-11.
-
(2004)
Cancer Res
, vol.64
, pp. 5702-5711
-
-
Draffin, J.E.1
McFarlane, S.2
Hill, A.3
Johnston, P.G.4
Waugh, D.J.5
-
104
-
-
0033595125
-
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells
-
Tuck AB, Arsenault DM, O’Malley FP, Hota C, Ling MC, Wilson SM, et al. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 1999;18:4237-46.
-
(1999)
Oncogene
, vol.18
, pp. 4237-4246
-
-
Tuck, A.B.1
Arsenault, D.M.2
O’Malley, F.P.3
Hota, C.4
Ling, M.C.5
Wilson, S.M.6
-
105
-
-
0038488950
-
A multigenic program mediating breast cancer metastasis to bone
-
Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-49.
-
(2003)
Cancer Cell
, vol.3
, pp. 537-549
-
-
Kang, Y.1
Siegel, P.M.2
Shu, W.3
Drobnjak, M.4
Kakonen, S.M.5
Cordón-Cardo, C.6
-
106
-
-
79960117895
-
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
-
Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 2011;17:867-74.
-
(2011)
Nat Med
, vol.17
, pp. 867-874
-
-
Oskarsson, T.1
Acharyya, S.2
Zhang, X.H.3
Vanharanta, S.4
Tavazoie, S.F.5
Morris, P.G.6
-
107
-
-
67649311599
-
Latent bone metastasis in breast cancer tied to Src-dependent survival signals
-
Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009;16:67-78.
-
(2009)
Cancer Cell
, vol.16
, pp. 67-78
-
-
Zhang, X.H.1
Wang, Q.2
Gerald, W.3
Hudis, C.A.4
Norton, L.5
Smid, M.6
-
108
-
-
80054725681
-
Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs
-
Chen Q, Zhang XH, Massagué J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 2011;20:538-49.
-
(2011)
Cancer Cell
, vol.20
, pp. 538-549
-
-
Chen, Q.1
Zhang, X.H.2
Massagué, J.3
-
109
-
-
84927156917
-
Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer
-
Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, et al. Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. J Biol Chem 2015;290:9842-54.
-
(2015)
J Biol Chem
, vol.290
, pp. 9842-9854
-
-
Wu, K.1
Fukuda, K.2
Xing, F.3
Zhang, Y.4
Sharma, S.5
Liu, Y.6
-
110
-
-
84923248130
-
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
-
Cojoc M, Mäbert K, Muders MH, Dubrovska A. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol 2015;31:16-27.
-
(2015)
Semin Cancer Biol
, vol.31
, pp. 16-27
-
-
Cojoc, M.1
Mäbert, K.2
Muders, M.H.3
Dubrovska, A.4
-
111
-
-
78649338141
-
Autophagy and the integrated stress response
-
Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010;40:280-93.
-
(2010)
Mol Cell
, vol.40
, pp. 280-293
-
-
Kroemer, G.1
Mariño, G.2
Levine, B.3
-
112
-
-
84892569830
-
An overview of autophagy: Morphology, mechanism, and regulation
-
Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 2014;20:460-73.
-
(2014)
Antioxid Redox Signal
, vol.20
, pp. 460-473
-
-
Parzych, K.R.1
Klionsky, D.J.2
-
113
-
-
84894594752
-
Autophagy: Directed development
-
McCarthy N. Autophagy: directed development. Nat Rev Cancer 2014;14:74-5.
-
(2014)
Nat Rev Cancer
, vol.14
, pp. 74-75
-
-
McCarthy, N.1
-
114
-
-
0035863399
-
A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles
-
Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001;61:439-44.
-
(2001)
Cancer Res
, vol.61
, pp. 439-444
-
-
Paglin, S.1
Hollister, T.2
Delohery, T.3
Hackett, N.4
McMahill, M.5
Sphicas, E.6
-
115
-
-
0037306785
-
Molecular response of human glioblastoma multiforme cells to ionizing radiation: Cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy
-
Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S, Germano IM. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg 2003;98: 378-84.
-
(2003)
J Neurosurg
, vol.98
, pp. 378-384
-
-
Yao, K.C.1
Komata, T.2
Kondo, Y.3
Kanzawa, T.4
Kondo, S.5
Germano, I.M.6
-
116
-
-
84902134638
-
Induces autophagy-associated cell death via the Akt/mTOR pathway in MCF-7 human breast cancer cells
-
Lu J, Sun D, Gao S, Gao Y, Ye J, Liu P. Cyclovirobuxine D induces autophagy-associated cell death via the Akt/mTOR pathway in MCF-7 human breast cancer cells. J Pharmacol Sci 2014;125:74-82.
-
(2014)
J Pharmacol Sci
, vol.125
, pp. 74-82
-
-
Lu, J.1
Sun, D.2
Gao, S.3
Gao, Y.4
Ye, J.5
Liu, P.6
Cyclovirobuxine, D.7
-
117
-
-
34347404887
-
Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis
-
Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007;21:1621-35.
-
(2007)
Genes Dev
, vol.21
, pp. 1621-1635
-
-
Karantza-Wadsworth, V.1
Patel, S.2
Kravchuk, O.3
Chen, G.4
Mathew, R.5
Jin, S.6
-
118
-
-
34249863298
-
Autophagy suppresses tumor progression by limiting chromosomal instability
-
Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007;21:1367-81.
-
(2007)
Genes Dev
, vol.21
, pp. 1367-1381
-
-
Mathew, R.1
Kongara, S.2
Beaudoin, B.3
Karp, C.M.4
Bray, K.5
Degenhardt, K.6
-
119
-
-
21444442926
-
Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells
-
Ito H, Daido S, Kanzawa T, Kondo S, Kondo Y. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol 2005;26:1401-10.
-
(2005)
Int J Oncol
, vol.26
, pp. 1401-1410
-
-
Ito, H.1
Daido, S.2
Kanzawa, T.3
Kondo, S.4
Kondo, Y.5
-
120
-
-
84860343080
-
Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy
-
Chaterjee M, van Golen KL. Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy. Bone Marrow Res 2011;2011:362938.
-
(2011)
Bone Marrow Res
, vol.2011
-
-
Chaterjee, M.1
Van Golen, K.L.2
-
121
-
-
84861961464
-
Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells
-
Rao R, Balusu R, Fiskus W, Mudunuru U, Venkannagari S, Chauhan L, et al. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol Cancer Ther 2012;11:973-83.
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 973-983
-
-
Rao, R.1
Balusu, R.2
Fiskus, W.3
Mudunuru, U.4
Venkannagari, S.5
Chauhan, L.6
-
122
-
-
84877584521
-
Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells
-
Gong C, Bauvy C, Tonelli G, Yue W, Deloménie C, Nicolas V, et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene 2013;32:2261-72.
-
(2013)
Oncogene
, vol.32
, pp. 2261-2272
-
-
Gong, C.1
Bauvy, C.2
Tonelli, G.3
Yue, W.4
Deloménie, C.5
Nicolas, V.6
-
123
-
-
11144296871
-
Lysosomal targeting of E-cadherin: A unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions
-
Palacios F, Tushir JS, Fujita Y, D’Souza-Schorey C. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 2005;25:389-402.
-
(2005)
Mol Cell Biol
, vol.25
, pp. 389-402
-
-
Palacios, F.1
Tushir, J.S.2
Fujita, Y.3
D’souza-Schorey, C.4
-
124
-
-
36849072573
-
The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA
-
Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007;450:908-12.
-
(2007)
Nature
, vol.450
, pp. 908-912
-
-
Sharif, J.1
Muto, M.2
Takebayashi, S.3
Suetake, I.4
Iwamatsu, A.5
Endo, T.A.6
-
126
-
-
84870412337
-
Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells
-
Jin B, Ernst J, Tiedemann RL, Xu H, Sureshchandra S, Kellis M, et al. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep 2012;2: 1411-24.
-
(2012)
Cell Rep
, vol.2
, pp. 1411-1424
-
-
Jin, B.1
Ernst, J.2
Tiedemann, R.L.3
Xu, H.4
Sureshchandra, S.5
Kellis, M.6
-
127
-
-
84907905879
-
Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome
-
El Helou R, Wicinski J, Guille A, Adélaïde J, Finetti P, Bertucci F, et al. Brief reports: a distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome. Stem Cells 2014;32: 3031-6.
-
(2014)
Stem Cells
, vol.32
, pp. 3031-3036
-
-
El Helou, R.1
Wicinski, J.2
Guille, A.3
Adélaïde, J.4
Finetti, P.5
Bertucci, F.6
-
128
-
-
84922704098
-
Epigenetics of cancer stem cells: Pathways and therapeutics
-
Shukla S, Meeran SM. Epigenetics of cancer stem cells: pathways and therapeutics. Biochim Biophys Acta 2014;1840:3494-502.
-
(2014)
Biochim Biophys Acta
, vol.1840
, pp. 3494-3502
-
-
Shukla, S.1
Meeran, S.M.2
-
129
-
-
84862638243
-
Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN
-
Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, et al. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS One 2012;7:e39520.
-
(2012)
Plos One
, vol.7
-
-
Han, M.1
Liu, M.2
Wang, Y.3
Chen, X.4
Xu, J.5
Sun, Y.6
-
130
-
-
68049114782
-
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
-
Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009;138:592-603.
-
(2009)
Cell
, vol.138
, pp. 592-603
-
-
Shimono, Y.1
Zabala, M.2
Cho, R.W.3
Lobo, N.4
Dalerba, P.5
Qian, D.6
-
131
-
-
84906062671
-
MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer
-
Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat 2014;147:39-49.
-
(2014)
Breast Cancer Res Treat
, vol.147
, pp. 39-49
-
-
Gwak, J.M.1
Kim, H.J.2
Kim, E.J.3
Chung, Y.R.4
Yun, S.5
Seo, A.N.6
-
132
-
-
84901471917
-
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
-
Taube JH, Malouf GG, Lu E, Sphyris N, Vijay V, Ramachandran PP, et al. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep 2013;3:2687.
-
(2013)
Sci Rep
, vol.3
-
-
Taube, J.H.1
Malouf, G.G.2
Lu, E.3
Sphyris, N.4
Vijay, V.5
Ramachandran, P.P.6
|